CRE-话题@MedSci

#CRE#

72篇内容 | 2294人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1581490, encodeId=73fa158149093, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, objectTitle=Lancet Neurology：ORATORIO试验的长期随访：早期和持续ocrelizumab治疗对原发性进行性MS的疾病进展具有益处, objectType=article, longId=204334, objectId=30c92043341a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30c92043341a, replyNumber=0, likeNumber=90, createdTime=2020-12-10, rootId=0, userName=HinsMax, userId=4ca216802819, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30c92043341a, moduleTitle=Lancet Neurology：ORATORIO试验的长期随访：早期和持续ocrelizumab治疗对原发性进行性MS的疾病进展具有益处, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30c92043341a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581489, encodeId=92091581489c0, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, objectTitle=3.5亿美元，阿斯利康出售重磅药物Crestor欧洲权益, objectType=article, longId=204104, objectId=cb44204104d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb44204104d5, replyNumber=0, likeNumber=87, createdTime=2020-12-05, rootId=0, userName=HinsMax, userId=4ca216802819, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb44204104d5, moduleTitle=3.5亿美元，阿斯利康出售重磅药物Crestor欧洲权益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb44204104d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581488, encodeId=5cd71581488b6, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, objectTitle=Lancet Neurology：散发性Creutzfeldt-Jakob病新危险位点的鉴定和病因分析：全基因组关联研究, objectType=article, longId=202561, objectId=1add20256138, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1add20256138, replyNumber=0, likeNumber=65, createdTime=2020-10-29, rootId=0, userName=HinsMax, userId=4ca216802819, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1add20256138, moduleTitle=Lancet Neurology：散发性Creutzfeldt-Jakob病新危险位点的鉴定和病因分析：全基因组关联研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1add20256138)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581487, encodeId=5575158148e08, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, objectTitle=Nat Commun：靶向IL1β-NFKB/CREB-Wnt信号通路可用于防止乳腺癌骨转移, objectType=article, longId=192936, objectId=ea7319293620, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea7319293620, replyNumber=0, likeNumber=85, createdTime=2020-04-26, rootId=0, userName=HinsMax, userId=4ca216802819, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea7319293620, moduleTitle=Nat Commun：靶向IL1β-NFKB/CREB-Wnt信号通路可用于防止乳腺癌骨转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea7319293620)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581486, encodeId=b68615814861b, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, objectTitle=2019 AF-SCREEN 国际合作组织白皮书：卒中后房颤筛查, objectType=article, longId=184511, objectId=73341845111c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73341845111c, replyNumber=0, likeNumber=46, createdTime=2019-12-11, rootId=0, userName=HinsMax, userId=4ca216802819, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73341845111c, moduleTitle=2019 AF-SCREEN 国际合作组织白皮书：卒中后房颤筛查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73341845111c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581485, encodeId=415a158148545, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, objectTitle=中国NMPA批准Chipscreen Bioscience的Chidamide（Epidaza）用于乳腺癌, objectType=article, longId=183901, objectId=fc3c183901cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc3c183901cb, replyNumber=0, likeNumber=69, createdTime=2019-12-02, rootId=0, userName=HinsMax, userId=4ca216802819, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc3c183901cb, moduleTitle=中国NMPA批准Chipscreen Bioscience的Chidamide（Epidaza）用于乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc3c183901cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581484, encodeId=946b1581484f0, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, objectTitle=J Dent Res：Amelx-iCre转基因小鼠中Stim1对成釉细胞特异性的作用, objectType=article, longId=176126, objectId=4e7d1e612653, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e7d1e612653, replyNumber=0, likeNumber=62, createdTime=2019-07-26, rootId=0, userName=HinsMax, userId=4ca216802819, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e7d1e612653, moduleTitle=J Dent Res：Amelx-iCre转基因小鼠中Stim1对成釉细胞特异性的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e7d1e612653)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581483, encodeId=319f1581483e9, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, objectTitle=JCLA：中国散发性先天性心脏病患儿GATA4、NKX2‐5、TBX5、BMP4 CRELD1和22q11.2基因区域拷贝数的变化, objectType=article, longId=167627, objectId=5bf316e627f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5bf316e627f4, replyNumber=0, likeNumber=60, createdTime=2019-06-05, rootId=0, userName=HinsMax, userId=4ca216802819, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5bf316e627f4, moduleTitle=JCLA：中国散发性先天性心脏病患儿GATA4、NKX2‐5、TBX5、BMP4 CRELD1和22q11.2基因区域拷贝数的变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5bf316e627f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581482, encodeId=8d2b1581482b5, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, objectTitle=罗氏的抗CD20单抗ocrelizumab在英国获批上市，治疗原发性进行性多发性硬化症, objectType=article, longId=165885, objectId=92ae165885e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92ae165885e9, replyNumber=0, likeNumber=66, createdTime=2019-05-13, rootId=0, userName=HinsMax, userId=4ca216802819, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92ae165885e9, moduleTitle=罗氏的抗CD20单抗ocrelizumab在英国获批上市，治疗原发性进行性多发性硬化症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92ae165885e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581481, encodeId=de2b15814813c, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, objectTitle=Pancreas：他汀类药物对胰腺癌或有保护作用, objectType=article, longId=159968, objectId=fa32159968cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa32159968cd, replyNumber=0, likeNumber=81, createdTime=2019-02-15, rootId=0, userName=HinsMax, userId=4ca216802819, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa32159968cd, moduleTitle=Pancreas：他汀类药物对胰腺癌或有保护作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa32159968cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581480, encodeId=65c0158148032, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, objectTitle=Hum Mol Genet：纯合致病性错义变异拓宽了CREB3L1相关成骨不全的表型和突变谱, objectType=article, longId=158937, objectId=124215893eec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=124215893eec, replyNumber=0, likeNumber=61, createdTime=2019-01-27, rootId=0, userName=HinsMax, userId=4ca216802819, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=124215893eec, moduleTitle=Hum Mol Genet：纯合致病性错义变异拓宽了CREB3L1相关成骨不全的表型和突变谱, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=124215893eec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581479, encodeId=dae815814e92c, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, objectTitle=Nat Commun：雄激素剥夺通过CREB-EZH2-TSP1途径促进前列腺癌的神经内分泌分化和血管生成, objectType=article, longId=150806, objectId=f841150806d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f841150806d3, replyNumber=0, likeNumber=53, createdTime=2018-10-13, rootId=0, userName=HinsMax, userId=4ca216802819, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f841150806d3, moduleTitle=Nat Commun：雄激素剥夺通过CREB-EZH2-TSP1途径促进前列腺癌的神经内分泌分化和血管生成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f841150806d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581478, encodeId=d69315814e894, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, objectTitle=阿斯利康（AstraZeneca）1.1亿美元了结美国Seroquel / Crestor药物诉讼案, objectType=article, longId=146241, objectId=accc14624103, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=accc14624103, replyNumber=0, likeNumber=69, createdTime=2018-08-11, rootId=0, userName=HinsMax, userId=4ca216802819, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=accc14624103, moduleTitle=阿斯利康（AstraZeneca）1.1亿美元了结美国Seroquel / Crestor药物诉讼案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=accc14624103)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581477, encodeId=725f15814e7e8, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, objectTitle=NICE掉头支持罗氏的Ocrevus治疗多发性硬化症, objectType=article, longId=141577, objectId=74621415e717, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74621415e717, replyNumber=0, likeNumber=65, createdTime=2018-06-26, rootId=0, userName=HinsMax, userId=4ca216802819, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74621415e717, moduleTitle=NICE掉头支持罗氏的Ocrevus治疗多发性硬化症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74621415e717)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581476, encodeId=961615814e692, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, objectTitle=Neurology：病例：Creutzfeldt-Jakob病的DWI和脑电图表现, objectType=article, longId=138988, objectId=5ac3138988db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ac3138988db, replyNumber=0, likeNumber=67, createdTime=2018-05-25, rootId=0, userName=HinsMax, userId=4ca216802819, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ac3138988db, moduleTitle=Neurology：病例：Creutzfeldt-Jakob病的DWI和脑电图表现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ac3138988db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581475, encodeId=93c715814e5d0, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, objectTitle=Clin Exp Rheumatol：中国类风湿性关节炎登记（CREDIT）：中国类风湿性关节炎患者简介和缓解情况, objectType=article, longId=138119, objectId=fe75138119b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe75138119b1, replyNumber=0, likeNumber=84, createdTime=2018-05-16, rootId=0, userName=HinsMax, userId=4ca216802819, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe75138119b1, moduleTitle=Clin Exp Rheumatol：中国类风湿性关节炎登记（CREDIT）：中国类风湿性关节炎患者简介和缓解情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe75138119b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581474, encodeId=899a15814e496, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, objectTitle=Emerg Infect Dis：CRE防控需要打出组合拳！, objectType=article, longId=134844, objectId=6e2e134844ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e2e134844ba, replyNumber=0, likeNumber=69, createdTime=2018-04-12, rootId=0, userName=HinsMax, userId=4ca216802819, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e2e134844ba, moduleTitle=Emerg Infect Dis：CRE防控需要打出组合拳！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e2e134844ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581473, encodeId=e92f15814e318, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, objectTitle=Infect Cont Hosp Ep：防止CRE的院内传播，做好手卫生和接触隔离真的有效吗？, objectType=article, longId=132926, objectId=531b1329269a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=531b1329269a, replyNumber=0, likeNumber=58, createdTime=2018-03-21, rootId=0, userName=HinsMax, userId=4ca216802819, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=531b1329269a, moduleTitle=Infect Cont Hosp Ep：防止CRE的院内传播，做好手卫生和接触隔离真的有效吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=531b1329269a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581472, encodeId=43cf15814e2d0, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, objectTitle=一表教您CRE主动筛查谁？筛查哪儿？筛查频次？, objectType=article, longId=130651, objectId=948f13065150, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=948f13065150, replyNumber=0, likeNumber=192, createdTime=2018-02-27, rootId=0, userName=HinsMax, userId=4ca216802819, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=948f13065150, moduleTitle=一表教您CRE主动筛查谁？筛查哪儿？筛查频次？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=948f13065150)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581471, encodeId=a07815814e16f, content=<a href='/topic/show?id=2bc1519579' target=_blank style='color:#2F92EE;'>#CRE#</a>, objectTitle=Circulation：阜外医院唐熠达教授牵头CREATIVE研究：“新三联”抗血小板治疗安全有效, objectType=article, longId=128987, objectId=722412898e50, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=722412898e50, replyNumber=0, likeNumber=74, createdTime=2018-02-07, rootId=0, userName=HinsMax, userId=4ca216802819, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=722412898e50, moduleTitle=Circulation：阜外医院唐熠达教授牵头CREATIVE研究：“新三联”抗血小板治疗安全有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=722412898e50)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CRE

2020-05-29

HinsMax (审核中...)

前往app查看评论内容

#CRE#

Lancet Neurology：ORATORIO试验的长期随访：早期和持续ocrelizumab治疗对原发性进行性MS的疾病进展具有益处

2020-12-10

HinsMax (审核中...)

前往app查看评论内容

#CRE#

3.5亿美元，阿斯利康出售重磅药物Crestor欧洲权益

2020-12-05

HinsMax (审核中...)

前往app查看评论内容

#CRE#

Lancet Neurology：散发性Creutzfeldt-Jakob病新危险位点的鉴定和病因分析：全基因组关联研究

2020-10-29

HinsMax (审核中...)

前往app查看评论内容

#CRE#

Nat Commun：靶向IL1β-NFKB/CREB-Wnt信号通路可用于防止乳腺癌骨转移

2020-04-26

HinsMax (审核中...)

前往app查看评论内容

#CRE#

2019 AF-SCREEN 国际合作组织白皮书：卒中后房颤筛查

2019-12-11

HinsMax (审核中...)

前往app查看评论内容

#CRE#

中国NMPA批准Chipscreen Bioscience的Chidamide（Epidaza）用于乳腺癌

2019-12-02

HinsMax (审核中...)

前往app查看评论内容

#CRE#

J Dent Res：Amelx-iCre转基因小鼠中Stim1对成釉细胞特异性的作用

2019-07-26

HinsMax (审核中...)

前往app查看评论内容

#CRE#

JCLA：中国散发性先天性心脏病患儿GATA4、NKX2‐5、TBX5、BMP4 CRELD1和22q11.2基因区域拷贝数的变化

2019-06-05

HinsMax (审核中...)

前往app查看评论内容

#CRE#

罗氏的抗CD20单抗ocrelizumab在英国获批上市，治疗原发性进行性多发性硬化症

2019-05-13

HinsMax (审核中...)

前往app查看评论内容

#CRE#

Pancreas：他汀类药物对胰腺癌或有保护作用

2019-02-15

HinsMax (审核中...)

前往app查看评论内容

#CRE#

Hum Mol Genet：纯合致病性错义变异拓宽了CREB3L1相关成骨不全的表型和突变谱

2019-01-27

HinsMax (审核中...)

前往app查看评论内容

#CRE#

Nat Commun：雄激素剥夺通过CREB-EZH2-TSP1途径促进前列腺癌的神经内分泌分化和血管生成

2018-10-13

HinsMax (审核中...)

前往app查看评论内容

#CRE#

阿斯利康（AstraZeneca）1.1亿美元了结美国Seroquel / Crestor药物诉讼案

2018-08-11

HinsMax (审核中...)

前往app查看评论内容

#CRE#

NICE掉头支持罗氏的Ocrevus治疗多发性硬化症

2018-06-26

HinsMax (审核中...)

前往app查看评论内容

#CRE#

Neurology：病例：Creutzfeldt-Jakob病的DWI和脑电图表现

2018-05-25

HinsMax (审核中...)

前往app查看评论内容

#CRE#

Clin Exp Rheumatol：中国类风湿性关节炎登记（CREDIT）：中国类风湿性关节炎患者简介和缓解情况

2018-05-16

HinsMax (审核中...)

前往app查看评论内容

#CRE#

Emerg Infect Dis：CRE防控需要打出组合拳！

2018-04-12

HinsMax (审核中...)

前往app查看评论内容

#CRE#

Infect Cont Hosp Ep：防止CRE的院内传播，做好手卫生和接触隔离真的有效吗？

2018-03-21

HinsMax (审核中...)

前往app查看评论内容

#CRE#

一表教您CRE主动筛查谁？筛查哪儿？筛查频次？

2018-02-27

HinsMax (审核中...)

前往app查看评论内容

#CRE#

Circulation：阜外医院唐熠达教授牵头CREATIVE研究：“新三联”抗血小板治疗安全有效

2018-02-07

科室
- - 订阅+
  - 更多科室
工具
服务